General Information of This Metabolic Reaction (MR) (ID: MR005655)
Formula
SVG example
Hydrolyzationn
Reactant Vismodegib Product Vismodegib metabolite M3
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 2C9 (CYP2C9) DME Info
Metabolic Type Oxidation - Hydrolyzationn
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR005659 Vismodegib Vismodegib metabolite M1 Unclear Vismodegib [1], [2], [3]
MR005662 Vismodegib Vismodegib metabolite M14 Oxidation - Hydrolyzationn Vismodegib [1], [2], [3]
MR005661 Vismodegib Vismodegib metabolite M18 Oxidation - Oxidationn Vismodegib [1], [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR005656 Vismodegib metabolite M3 Vismodegib metabolite M18 Oxidation - Oxidationn Vismodegib [1], [2], [3]
MR005658 Vismodegib metabolite M3 Vismodegib metabolite M5 Conjugation - Glucuronidation Vismodegib [1], [2], [3]
References
1 A single dose mass balance study of the Hedgehog pathway inhibitor vismodegib (GDC-0449) in humans using accelerator mass spectrometry
2 Absorption, distribution, metabolism, and excretion of [1?C]GDC-0449 (vismodegib), an orally active hedgehog pathway inhibitor, in rats and dogs: a unique metabolic pathway via pyridine ring opening
3 Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.